| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.32% | -2.41% | +44.49% | +140.80% | 983B | |
| +1.27% | -1.85% | +54.41% | +39.65% | 557B | |
| +6.25% | +3.80% | +24.13% | +67.39% | 406B | |
| +1.34% | -1.93% | +23.33% | +16.35% | 314B | |
| +1.19% | +1.46% | +29.35% | +18.00% | 273B | |
| +1.31% | +1.34% | +27.58% | +33.75% | 272B | |
| +1.19% | +7.65% | -33.04% | -44.55% | 203B | |
| +2.11% | -1.66% | +19.14% | +50.10% | 186B | |
| +0.90% | +0.46% | +15.09% | +59.86% | 155B | |
| Average | +1.58% | -0.92% | +22.72% | +42.37% | 372.26B | |
| Weighted average by Cap. | +1.62% | -2.22% | +31.60% | +64.66% |
Employees
4
Sector
Pharmaceuticals
